Get the Stockscreener App
10.71
2.39%
0.25
Medifast Inc stock is traded at $10.71, with a volume of 150.78K.
It is up +2.39% in the last 24 hours and down -3.86% over the past month.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
See More
Previous Close:
$10.46
Open:
$10.56
24h Volume:
150.78K
Relative Volume:
0.59
Market Cap:
$117.72M
Revenue:
$1.07B
Net Income/Loss:
$99.41M
P/E Ratio:
1.1821
EPS:
9.06
Net Cash Flow:
$141.17M
1W Performance:
+0.56%
1M Performance:
-3.86%
6M Performance:
-22.67%
1Y Performance:
-24.74%
1-Day Range:
$10.36
$10.75
1-Week Range:
$10.18
$10.77
52-Week Range:
$10.10
$15.46
Medifast Inc Stock (MED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
(410) 581-8042
Address
100 INTERNATIONAL DRIVE, BALTIMORE, MD
Compare MED vs ROL, SCI, FTDR, BFAM, HRB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
10.71 | 114.97M | 1.07B | 99.41M | 141.17M | 9.06 |
|
ROL
Rollins Inc
|
58.00 | 28.95B | 3.76B | 526.71M | 650.02M | 1.0878 |
|
SCI
Service Corp International
|
82.01 | 11.89B | 4.29B | 534.77M | 573.95M | 3.7085 |
|
FTDR
Frontdoor Inc
|
67.90 | 4.98B | 2.04B | 263.00M | 345.00M | 3.515 |
|
BFAM
Bright Horizons Family Solutions Inc
|
75.76 | 4.24B | 2.63B | 116.59M | 215.93M | 1.99 |
|
HRB
H R Block Inc
|
30.85 | 3.99B | 3.71B | 564.15M | 648.29M | 4.08 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Upgrade | DA Davidson | Underperform → Neutral |
| Jun-05-24 | Downgrade | DA Davidson | Neutral → Underperform |
| Oct-13-23 | Initiated | Stephens | Equal-Weight |
| Nov-04-22 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-04-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-25-21 | Upgrade | Jefferies | Hold → Buy |
| Nov-05-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-25-20 | Initiated | B. Riley FBR | Buy |
| Feb-27-20 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-19 | Downgrade | Dougherty & Company | Buy → Neutral |
| Jul-25-19 | Initiated | Jefferies | Buy |
| Nov-08-18 | Upgrade | Sidoti | Neutral → Buy |
| Mar-07-18 | Upgrade | Sidoti | Neutral → Buy |
| Sep-15-17 | Reiterated | DA Davidson | Buy |
| Aug-04-16 | Reiterated | Wunderlich | Hold |
| Jan-11-16 | Upgrade | Sidoti | Neutral → Buy |
| Nov-30-15 | Downgrade | Sidoti | Buy → Neutral |
| Oct-05-15 | Upgrade | Sidoti | Neutral → Buy |
| Nov-07-14 | Downgrade | Imperial Capital | Outperform → In-line |
| Aug-08-14 | Reiterated | Imperial Capital | Outperform |
| Apr-23-14 | Reiterated | Imperial Capital | Outperform |
| Sep-06-13 | Initiated | Imperial Capital | Outperform |
| Nov-06-12 | Reiterated | Northland Securities | Outperform |
| Jul-27-12 | Upgrade | Northland Securities | Market Perform → Outperform |
| Jul-09-12 | Downgrade | Standpoint Research | Buy → Hold |
| Jan-30-12 | Initiated | Standpoint Research | Buy |
View All
Medifast Inc Stock (MED) Latest News
MED PE Ratio & Valuation, Is MED Overvalued - Intellectia AI
MED Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Medifast (MED) price target decreased by 20.00% to 12.24 - MSN
Medifast (MED) Price Target Decreased by 20.00% to 12.24 - Nasdaq
Medifast's Q4 Earnings Call: Our Top 5 Analyst Questions - Finviz
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Medifast’s Fourth Quarter Earnings Conference: The Five Key Questions from Analysts - Bitget
MED Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Medifast (NYSE:MED) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Aug Big Picture: Is Medifast Inc gaining market shareTrade Volume Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
How Medifast Inc. (MDF) stock reacts to new regulationsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - mfd.ru
Will Medifast Inc. benefit from government policyWeekly Stock Analysis & Real-Time Volume Trigger Notifications - mfd.ru
Use HSA/FSA dollars on OPTAVIA’s metabolic health plan from Medifast - Stock Titan
Weight Loss and Diet Management Analysis Report 2026-2035: A $45+ Billion Market by 2030 with Weight Watchers, Nutrisystem, Kellogg, Herbalife, Apollo Endosurgery, and Medifast Leading - Yahoo Finance
Stephens cuts Medifast stock price target to $12 on margin pressures - Investing.com Nigeria
Stephens cuts Medifast stock price target to $12 on margin pressures By Investing.com - Investing.com Canada
Medifast (MED): Analyst Maintains Rating, Lowers Price Target to $12 | MED Stock News - GuruFocus
Stephens Lowers Medifast (NYSE:MED) Price Target to $12.00 - MarketBeat
Medifast Q4 Earnings Call Highlights - Defense World
Medifast Earnings Call Maps Risky Turnaround Path - TipRanks
Public company to leave Harbor East headquarters - The Business Journals
Medifast Q4 2025 slides: pivots to metabolic health amid continued losses - Investing.com Australia
Medifast outlines $270M–$300M 2026 revenue target as CEO transition and metabolic health focus drive execution - MSN
Medifast Q4 Loss Wider Than Expected, Revenues Decline 37% Y/Y - Yahoo Finance
Medifast (NYSE:MED) Posts Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat
Medifast, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Medifast, Inc. (NYSE:MED) Q4 2025 Earnings Call Transcript - Insider Monkey
MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains - The Globe and Mail
Medifast Q4 2025 slides: pivots to metabolic health amid continued losses By Investing.com - Investing.com South Africa
Earnings call transcript: Medifast Q4 2025 shows significant EPS miss By Investing.com - Investing.com South Africa
Medifast CEO Transition and Q4 2025 Earnings Insights - Intellectia AI
Medifast (NYSE:MED) Releases FY 2026 Earnings Guidance - MarketBeat
Medifast (NYSE:MED) Updates Q1 2026 Earnings Guidance - MarketBeat
Medifast Q4 2025 Earnings Call Transcript - MarketBeat
Medifast Inc (NYSE:MED) Reports Mixed Q4 Results with Deepening Losses and Challenging 2026 Outlook - ChartMill
Medifast (MED) Q4 2025 Earnings Call Transcript - AOL.com
Medifast : Fourth Quarter and Full Year 2025 Earnings Webcast (Medifast Fourth Quarter and Full Year 2025 Earnings Supplement) - marketscreener.com
Earnings call transcript: Medifast Q4 2025 shows significant EPS miss - Investing.com
Medifast's (NYSE:MED) Q4 CY2025 Sales Top Estimates - Finviz
Medifast (MED) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
MEDIFAST INC SEC 10-K Report - TradingView
Medifast: Q4 Earnings Snapshot - WKYC
Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates - Yahoo Finance
Medifast : Fourth Quarter 2025 Medifast Fourth Quarter and Full Year 2025 Earnings Supplement - marketscreener.com
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
What to Expect from Medifast's Earnings - Benzinga
Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow - Finviz
Medifast Inc Stock (MED) Financials Data
Revenue
Net Income
Cash Flow
EPS
14.49%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):